XGN
#3681
Exagen Inc. - Common Stock
7.5 2 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.96%
Monthly Change
+68.61%
6 month change
+112.43%
Year Change
-22.95%
Previous Close
7.6 7
Open
7.5 2
Low
7.5 2
High
7.5 2
Volume
11
Financials
- Market Capitalization 182.17 M
- Employee 220
- Founded 2002
- CEO N/A
- Website www.exagen.com
- Headquarter Delaware, United States
- FIGI BBG00178FZY1
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.54
Price to sales ratio
1.97
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3468 |  LAB Standard BioTools Inc. - Common Stock | 0.65 USD | 0.00% | +3.17% | -16.67% | -50.38% | 255.18 M USD | ||
| 3555 |  STIM Neuronetics, Inc. - Common Stock | 2.96 USD | -1.33% | -5.43% | +59.14% | -14.45% | 225.54 M USD | ||
| 3796 |  IMDX Insight Molecular Diagnostics Inc. - Common Stock | 4.29 USD | -0.23% | -2.50% | -6.54% | +70.98% | 140.39 M USD | ||
| 3914 |  BNR Burning Rock Biotech Limited - American Depositary Shares | 10.00 USD | -4.21% | +6.38% | +12.23% | -66.58% | 108.21 M USD |
Frequently asked questions about Exagen Inc. Common Stock
What is the Exagen Inc. Common Stock stock price today?
The current price of Exagen Inc. Common Stock (XGN) is 7.52. Over the past 24 hours, the stock has changed by -1.96%. Follow the XGN chart for real-time price dynamics.
What is the stock ticker of Exagen Inc. Common Stock?
Exagen Inc. Common Stock trades under the ticker XGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Exagen Inc. Common Stock stock going up?
XGN has changed by -3.09% over the last week, +68.61% over the last month, and -22.95% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Exagen Inc. Common Stock?
Exagen Inc. Common Stock currently has a market capitalization of 182.17 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Exagen Inc. Common Stock earnings last quarter?
Last quarter, Exagen Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Exagen Inc. Common Stock revenue for the last quarter?
Exagen Inc. Common Stock reported quarterly revenue of 19.94 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Exagen Inc. Common Stock net income for the last quarter?
Exagen Inc. Common Stock reported net income of -3.2 M for the last quarter. The previous quarter showed -3.97 M, which means net income changed by +19.44%.
How many employees does Exagen Inc. Common Stock have?
As of the latest available data, Exagen Inc. Common Stock has 220 employees. Workforce size can provide additional context about the company's scale and operations.
What is Exagen Inc. Common Stock EBITDA?
Exagen Inc. Common Stock EBITDA is 6.6 M, and its EBITDA margin is 33.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Exagen Inc. Common Stock stock?
You can buy Exagen Inc. Common Stock (XGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Exagen Inc. Common Stock stock?
Investing in Exagen Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XGN chart and related analysis on metatrader.com as part of your research.